Red Light, Green Light: Canine Appetite Stimulants

Sponsored by Elanco

Inappetence can be associated with a variety of conditions in the canine population. Regardless of whether it is caused by chronic disease (eg, cancer, kidney disease) or a period of temporary stress or anxiety, early intervention is critical to reduce the risk for continued weight loss and other secondary complications.

Entyce™ (capromorelin oral solution) is the only FDA-approved appetite stimulant for use in dogs. Entyce is a selective ghrelin receptor agonist that influences signaling in the hypothalamus to stimulate appetite while also stimulating the secretion of growth hormone.¹ Entyce should be used with caution in dogs with renal or hepatic insufficiency.¹ Its use has not been evaluated in breeding, pregnant, or lactating dogs.¹